EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulation of Intestinal Butyrate Transporters by Oxidative and Inflammatory Status

Fátima Martel iD

Antioxidants · 30.12.2025 · 15 (1) · 48

DOI: 10.3390/antiox15010048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 30.12.2025. Verfasst von Fátima Martel. Beteiligte Einrichtung: Unit of Biochemistry, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beneficial effects of the microbiota-derived metabolite butyrate at the colonic level are well established, particularly through its relevance in colorectal cancer (CRC) and inflammatory bowel disease (IBD), two major intestinal pathologies. Therefore, the mechanisms involved in butyrate transport across colonic epithelial cell membranes (uptake transporters: monocarboxylate transporter 1 (MCT1) and sodium-coupled monocarboxylate transporter 1 (SMCT1); efflux transporters: breast cancer resistance protein (BCRP) and MCT1/monocarboxylate transporter 4 (MCT4)), which are determinant for its intracellular levels, are of primary importance for its beneficial effects at the colonic level. The available data suggest that all these butyrate transporters can be modulated by redox and inflammatory status, but the evidence is scarce and rather inconsistent. Nevertheless, a role of nuclear factor erythroid 2-related factor 2 (Nrf2) and of the proinflammatory cytokines tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) in mediating the effect of oxidative stress and inflammation, respectively, on MCT1 and SMCT1 is suggested. So, more investigation on this subject is needed, given the fact that increased oxidative stress levels and inflammatory status are present in a series of intestinal conditions and pathologies, including CRC and IBD, which could help to establish these transporters as potential cellular targets in these diseases.

Schlagwörter

Stichwörter der Autor:innen

butyrate transporterscolorectal cancerinflammationinflammatory bowel diseaseintestineoxidative stress

Autor:innen und Institutionen

  • Unit of Biochemistry, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
  • Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.

ORCID-Profile: Fátima Martel

Zitieren

APA

Martel, F. (2025). Regulation of Intestinal Butyrate Transporters by Oxidative and Inflammatory Status. Antioxidants, 15(1), 48. https://doi.org/10.3390/antiox15010048

Vancouver

Martel F. Regulation of Intestinal Butyrate Transporters by Oxidative and Inflammatory Status. Antioxidants. 2025;15(1):48. doi:10.3390/antiox15010048

BibTeX
@article{Martel2025,
  author = {Martel, Fátima},
  title = {Regulation of Intestinal Butyrate Transporters by Oxidative and Inflammatory Status},
  journal = {Antioxidants},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {48},
  doi = {10.3390/antiox15010048}
}
Kostenlos starten →